Split History
ETFs Holding PIP »    PIP Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Altimmune is a biodefense company engaged in developing medical counter measures against biological and chemical threats. Co.'s Anthrax vaccines use Recombinant Protective Antigen (rPA), rPA manufacturing processes and development technologies to develop vaccines. Co. has a contract for preclinical development of a lyophilized anthrax vaccine based on Co.'s proprietary technology platform which contributes the rPA bulk drug substance. Co. has a license agreement with ImmunoVaccine Technologies for the use of the DepoVax™ vaccine platform to develop an anthrax vaccine utilizing Co.'s rPA. According to our PIP split history records, PIP has had 1 split.
PIP split history picture
PIP (PIP) has 1 split in our PIP split history database. The split for PIP took place on May 05, 2017. This was a 1 for 10 reverse split, meaning for each 10 shares of PIP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as PIP conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the PIP split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PIP shares, starting with a $10,000 purchase of PIP, presented on a split-history-adjusted basis factoring in the complete PIP split history. PIP split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 01/20/2009
End date: 11/28/2017
Start price/share: $23.90
End price/share: $6.50
Starting shares: 418.41
Ending shares: 1,623.93
Dividends reinvested/share: $29.10
Total return: 5.56%
Average Annual Total Return: 0.61%
Starting investment: $10,000.00
Ending investment: $10,553.62
Years: 8.86
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/20/2009
End date: 11/28/2017
Start price/share: $23.90
End price/share: $6.50
Dividends collected/share: $29.10
Total return: 48.95%
Average Annual Total Return: 4.60%
Starting investment: $10,000.00
Ending investment: $14,895.53
Years: 8.86
Date Ratio
05/05/20171 for 10
PIP is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

PKI Split History
PLI Split History
PLX Split History
PLXP Split History
PMD Split History
PPHM Split History
PRAN Split History
PRGO Split History
PRSN Split History
PRTK Split History

Enghouse Systems Limited (ENGH.CA)
Camber Energy, Inc. (CEI)
IRET (IRET)
Diffusion Pharmaceuticals Inc. (DFFN)
Tonix Pharmaceuticals Holding Corp. (TNXP)
SPI Energy Co., Ltd. (SPI)
Spirit Realty Capital, Inc. (SRC)
ReShape Lifesciences Inc. (RSLS)
Churchill Downs Incorporated (CHDN)
Rollins, Inc. (ROL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

PIP Insider Buying

PIP Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.